期刊文献+

中西医结合治疗脓毒性休克早期复苏的干预研究 被引量:6

下载PDF
导出
摘要 [目的]观察参附注射液对脓毒性休克早期复苏治疗效果。[方法]脓毒性休克患者92例随机分为中西医结合治疗组和对照组,治疗组在对照组的治疗基础上早期加用参附注射液治疗。[结果]中西医结合治疗前两组患者血压、心率、尿量、CRT、乳酸水平比较差异无统计学意义(P﹥0.05);治疗6小时后,中西医结合治疗组与对照组患者的血压、心率、尿量、CRT、血乳酸水平比较,差异有统计学意义(P﹤0.05);中西医结合治疗组治疗前与治疗6小时后以上指标差异有统计学意义(P<0.05),中西医结合治疗72小时后治疗组与对照组患者的多器官功能障碍(MODS)发生率和死亡率比较,差异均有统计学意义。[结论]治疗组在早期稳定血流动力学方面作用明显,参附注射液治疗脓毒性休克早期复苏有效安全,并且能减少血管活性药物的应用。
出处 《卫生软科学》 2012年第6期578-580,共3页 Soft Science of Health
  • 相关文献

参考文献10

  • 1Shapiro NI. Howell M. Talmor D. A blueprint for a sepsis protocol [J]. Acad Emerg Med, 2005, 12 (4) :352-359.
  • 2Angus DC, Birmingham MC, Balk RA, et al. E5 murine monoclonal antiendotoxin antibody in gram-negative sepsis: a randomized controlled trial[J]. JAMA, 2000, 283 (17): 1723-1730.
  • 3DellingerRP, CarletJM, Masur H, et al. Surviving sepsis campaign guidelines for management of sever sepsis and septic shock[J].Crit Care Med, 2004,32 (3) :858-873.
  • 4Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP /ATS/SIS International Sepsis Definitions Conference[J]. Crit Care Med, 2003, 31 (4) : 1250-1256.
  • 5Angus DC, Linde-ZwirbleWT, Lidicker J, et al. Epdiemiology of severe sepsis in the United States: analysis of incidence, outcome and associated costs of care[J]. Crit Care Clin, 2001,29(7):1303-1310.
  • 6Puskarieh MA, Marehick MR, Kline JA, et al. One year mortality of patients treated with an emergency department based early goal directed therapy protocol for severe sepsis and septic shock: a before and after study[J]. Crit Care, 2009, 13 (5) :R167.
  • 7Focht A, Jones AE, Lowe TT. Early goal-directed therapy: improving mortality and morbidity of sepsis in the emergency department[J]. Jt Comm J Qual Patient Saf, 2009, 35(4):186-191.
  • 8马艳平,刘革命,王夜.参附注射液联合舒血宁注射液治疗冠心病心绞痛临床观察[J].中国中医急症,2009,18(9):1443-1444. 被引量:6
  • 9莫成荣,赵永华.参附注射液治疗急性心肌梗塞并心衰30例观察[J].中国中医急症,2001,10(4):213-213. 被引量:22
  • 10杨进国,刘先义,杜大平.参附注射液对败血性休克大鼠心肌损伤的影响[J].武汉大学学报(医学版),2005,26(2):168-171. 被引量:24

二级参考文献13

  • 1董泉珍.中西医结合治疗心力衰竭的探讨[J].中国中西医结合杂志,1996,16(12):745-748. 被引量:79
  • 2国际心脏病学会和协会及WHO命名标准化联合专题组.缺血性心脏病命名及诊断标准[J].中华心血管病杂志,1981,9(1):75-75.
  • 3陈国伟.现代急诊内科学[M].广州:广东科学技术出版社,1996.275-276.
  • 4刘因伏 吴宁 等.心血管药物临床实验方法的建议[J].中华心血管杂志,1998,26:405-405.
  • 5中西医结合治疗冠心病心绞痛及心律失常座谈会;冠心病心绞痛及心电图疗效评定标准.中国药事,1987,1(2):71-71.
  • 6王津文,史卫国,毕建亭.丹红注射液对不稳定型心绞痛病人炎症反应物及纤溶活性的影响[J].中西医结合心脑血管病杂志,2007,5(8):673-675. 被引量:31
  • 7Hassoun HT, Kozar RA, Kone BC, et al. Intraischemic hypothermia differentially modulates oxidative stress proteins during mesenteric ischemia/reperfusion. Surgery, 2002, 132: 369.
  • 8Haudek SB, Spencer E. Overexpression of cardiac I-kappa Balpha prevent endotoxin- induced myocardial dysfunction. Am J Physiol Heart Circ Physiol,2001, 280(3):H962.
  • 9Meldrum DR, Donnahoo KK. Role of TNF-α in mediating renal insufficiency following cadiac surgery: evidence of a postbypass cardiorenal syndrome. J Surg Res,1999,85(2):185.
  • 10Oberholzer A, Oberholzer C, Moldawer LL. Sepsis syndromes: understanding the role of innate and acquired immunity. Shock, 2001, 16(2): 83.

共引文献48

同被引文献121

引证文献6

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部